000 | 01599 a2200433 4500 | ||
---|---|---|---|
005 | 20250515065947.0 | ||
264 | 0 | _c20071213 | |
008 | 200712s 0 0 eng d | ||
022 | _a1551-4005 | ||
024 | 7 |
_a10.4161/cc.6.10.4182 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonuccelli, Gloria | |
245 | 0 | 0 |
_aLocalized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice. _h[electronic resource] |
260 |
_bCell cycle (Georgetown, Tex.) _cMay 2007 |
||
300 |
_a1242-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 |
_aDipeptides _xpharmacology |
650 | 0 | 4 |
_aDystrophin _xmetabolism |
650 | 0 | 4 |
_aDystrophin-Associated Proteins _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred mdx |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 |
_aMuscle, Skeletal _xmetabolism |
650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPyrazines _xpharmacology |
700 | 1 | _aSotgia, Federica | |
700 | 1 | _aCapozza, Franco | |
700 | 1 | _aGazzerro, Elisabetta | |
700 | 1 | _aMinetti, Carlo | |
700 | 1 | _aLisanti, Michael P | |
773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 6 _gno. 10 _gp. 1242-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4161/cc.6.10.4182 _zAvailable from publisher's website |
999 |
_c17040797 _d17040797 |